1. Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital.
- Author
-
Pimpalkhute, Sonali A., Bajait, Chaitali S., Dakhale, Ganesh N., Sontakke, Smita D., Jaiswal, Kavita M., and Kinge, Parag
- Subjects
QUALITY of life measurement ,PEOPLE with epilepsy ,ANTICONVULSANTS ,TERTIARY care ,TREATMENT of epilepsy ,CARBAMAZEPINE - Abstract
Objectives: Health-related quality of life (QOL) is an important outcome in epilepsy treatment. Very few studies have been carried out on the quality of life in epilepsy (QOLIE-31) in India. The present study aimed to determine the level of health-related QOLIE-31 in patients of epilepsy. Materials and Methods: This was a cross-sectional, questionnaire-based study conducted in a tertiary care teaching hospital. Respondents were adults aged at least 18-year-old with a diagnosis of epilepsy. QOLIE-31 was used for collecting data on health-related QOL. The unpaired t-test or one-way analysis of variance was used to compare means of QOL scores between groups. Results: Totally, 60 patients of epilepsy were included in the study. The mean (standard deviation) total score of QOLIE-31 was 64.61. A score of cognitive and medication effect were significantly better in carbamazepine group as compared to valproate group. Conclusions: Patients on monotherapy had a better QOL as compared to patients receiving polytherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF